Hormone therapy
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Hormone therapy, covering 2009-07-31 to 2023-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide. [Phase 3]